New fill/finish partnership with BioConnection provides end-to-end drug product development under 1 contract!   Read the press release

1 min read

CDCM 8th Annual Symposium, March 13

CDCM 8th Annual Symposium, March 13

Date: March 13, 2024 | 8:00 a.m. - 5:30 p.m. PDT

Location: Stanford University School Medicine - Directions

Event Website: https://med.stanford.edu/cdcm/events/8th-cdcm-symposium-test.html 

 

Join us at the event!

We hope you'll join us at this amazing event to explore new discoveries in regenerative medicine and clinical trials in this one-day conference.

Click the link above to get all the details. 

 

REQUEST A MEETING

You can also reach out directly to our expert attending the Symposium

Raghu Malapaka
Sr. Director, Business Development - Cell & Gene Therapy
Email  me

Learn about our cell and gene therapy services 

Cell Therapy Development and Manufacturing

AGC Biologics’ cell therapy services support every stage of the product journey, from pre-clinical through commercialization. At our Milan and Longmont facilities, we can work with virtually any cell type – including Human Mesenchymal Stem Cells (hMSCs), Exosomes, CD34+, T-Cells, NK Cells, and more.  

Using the latest autologous and allogeneic methods, we help your products meet the exact specifications for patients in a clinical or commercial setting. 

Cell therapy services 

Viral Vector Development and Manufacturing 

AGC Biologics scientists have two decades of viral vector-based gene therapy expertise and specialize in adeno-associated viral vectors (AAV), lentiviral vectors (LVV), and retroviral vectors (RVV). Our sites in the U.S. and Italy have supported four commercial products. 

Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes, designed entirely in-house. 

Viral vector services 

Plasmid DNA (pDNA) Materials 

To support your pDNA needs, AGC Biologics utilizes a customized process based on your specific plasmid and hosting system. We have extensive technical expertise in fermentation, purification, and analytics, and our highly experienced teams routinely manufacture GMP-grade pDNA materials. This work includes starting material for gene therapy, and viral vector manufacturing. 

Plasmid offering

Fill out the form below to request a meeting during the event